Advertisement
Home Tags Cancer: Misc.

Tag: Cancer: Misc.

August 2015 Briefing – Hematology & Oncology

0
Here are what the editors at HealthDay consider to be the most important developments in Hematology & Oncology for August 2015. This roundup includes...
For some pediatric cancer patients with relapsed or refractory cancer

Genomic Sequencing Benefits Some Childhood Cancer Patients

0
Benefits seen for some children and young adults with relapsed or refractory cancer
Physicians whose peers were early adopters of brachytherapy for the treatment of women with early-stage breast cancer are more likely to adopt the therapy themselves

Physicians’ Peers Influence Use of New Cancer Tx Modalities

0
Exposure to peers who were early adopters of brachytherapy associated with increased use
In patients with newly diagnosed multiple myeloma

Continuous Therapy Improves Survival in Multiple Myeloma

0
Benefit seen in progression-free, overall survival compared with fixed duration of therapy
Many elderly oncology patients use complementary and alternative medications

Many Elderly Oncology Patients Taking Alternative Medicines

0
Associated with polypharmacy, vision impairment, and urologic comorbidities
Daratumumab monotherapy has a favorable safety profile and encouraging efficacy in patients with heavily pretreated and refractory myeloma in a phase 1-2 trial. The results of the study were published online Aug. 26 in the New England Journal of Medicine.

Daratumumab Monotherapy Promising for Multiple Myeloma

0
Findings in a phase 1-2 study of patients with relapsed myeloma or relapsed/refractory myeloma
For some

BRAF V600 Is Targetable in Some Nonmelanoma Cancers

0
Vemurafenib active in NSCLC, Erdheim-Chester disease, Langerhans'-cell histiocytosis
The risk of alcohol-related cancer is increased even with light to moderate drinking in women

Even Light Drinking Increases Risk of Breast Cancer in Women

0
For women, alcohol consumption of 5 to 14.9 g/day linked to increased risk of alcohol-related cancers
For patients with active cancer and acute symptomatic venous thromboembolism (VTE)

Full-Dose Tinzaparin Doesn’t Cut Risk of Recurrent VTE in CA

0
No difference in major bleeding, overall mortality, but reduction in clinically relevant nonmajor bleeding
Survivors of childhood cancer have an increased long-term risk of intestinal obstruction requiring surgery

Child CA Survivors Face Risk of Bowel Obstruction Requiring Sx

0
Survivors of childhood cancer, especially those with abdominopelvic tumors, have higher long-term risk